News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Benefit of olaparib maintenance in 140 patients with ovarian cancer – ESMO Open
Photo: Depositphotos
Apr 6, 2025, 14:19

Benefit of olaparib maintenance in 140 patients with ovarian cancer – ESMO Open

ESMO Open shared a post on X about a recent paper by Claudia Marchetti et al. published in ESMO Open:

“Benefit of olaparib maintenance in 140 patients with ovarian cancer, by BRCA mutation type and site. BRCA1-mutated patients in the RING or BRCT and BRCA2-mutated in the RAD51-BD appear to have the greatest benefit from adjuvant olaparib.”

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

Authors: Claudia Marchetti et al.

Benefit of olaparib maintenance

Explore more insights and listen to podcast on Ovarian Cancer on OncoDaily.

Benefit of olaparib maintenance

Benefit of olaparib maintenance

BRCT cancer Claudia Marchetti ESMO Open OncoDaily Oncology Ovarian Cancer RING
Special Coverage
Blog
Apr 6, 2025, 14:47
Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
Dialogues
Apr 6, 2025, 14:37
Rise and Fall: The Shocking Diagnosis at the Peak of Success | Sonny Shnayderman's story
Insight
Apr 6, 2025, 14:35
Gertjan Kaspers: Princess Máxima Center Signs Memorandum of Understanding with Uruguay’s Pediatric Oncology Center
Blog
Apr 6, 2025, 14:30
Gustavo Viani: HDR vs LDR Boost in Prostate Cancer
Positive
Apr 6, 2025, 14:23
Eugene Woods: Proud to launch the Pediatric Hospital at Home
Insight
Apr 6, 2025, 14:19
Benefit of olaparib maintenance in 140 patients with ovarian cancer - ESMO Open
Blog
Apr 6, 2025, 14:10
Ginny Mason: Have you registered for the ABC8 Conference yet?
Blog
Apr 6, 2025, 14:06
Molecular Hyperselection for Optimal First-Line Targeted Therapy in RAS Wild-Type Metastatic Colorectal Cancer
Blog
Apr 6, 2025, 13:57
David Planchard: First patient included in the INDIGO study
Blog
Apr 6, 2025, 13:46
Terri Hansel: Proud of the incredible work at St. Elizabeth Breast Center and the Yung Family Center
Celebrities
Apr 6, 2025, 13:44
Cynthia Nixon's Breast Cancer Journey: How She Went Against, Survived, and More
Blog
Apr 6, 2025, 13:40
Oscar Tahuahua: Neoadjuvant Aumolertinib in stage III EGFR+ NSCLC